Vertex to Acquire Crinetics Pharmaceuticals On July 6, Vertex Pharmaceuticals, Inc., and Crinetics Pharmaceuticals, Inc., a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of […]
Pharma Friday – July 10, 2026
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. *
Join the Global Movement Advancing Endocrine Science and Medicine
Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.